Re: Pareek A, Chandurkar N, Thomas N, et al. Efficacy and safety of hydroxychloroquine in the treatment of type 2 diabetes mellitus: a double blind, randomized comparison with pioglitazone. Curr Med Res Opin 2014;30:1257-66

Affiliations

Comment

Anil Pareek. Curr Med Res Opin. 2015 Jun.

. 2015 Jun;31(6):1087-92.

doi: 10.1185/03007995.2015.1035242.

¹ President - Medical Affairs and Clinical Research Ipca Laboratories Limited , 142-AB Kandivli Industrial Estate, Kandivli (West) Mumbai: 400067 , India.

No abstract available

Comment on

Efficacy and safety of hydroxychloroquine in the treatment of type 2 diabetes mellitus: a double blind, randomized comparison with pioglitazone.
Pareek A, Chandurkar N, Thomas N, Viswanathan V, Deshpande A, Gupta OP, Shah A, Kakrani A, Bhandari S, Thulasidharan NK, Saboo B, Devaramani S, Vijaykumar NB, Sharma S, Agrawal N, Mahesh M, Kothari K. Pareek A, et al. Curr Med Res Opin. 2014 Jul;30(7):1257-66. doi: 10.1185/03007995.2014.909393. Epub 2014 May 2. Curr Med Res Opin. 2014. PMID: 24669876 Clinical Trial.
Re: Pareek A, Chandurkar N, Thomas N, et al. Efficacy and safety of hydroxychloroquine in the treatment of type 2 diabetes mellitus: a double blind, randomized comparison with pioglitazone. Curr Med Res Opin 2014;30:1257-66.
Charan J. Charan J. Curr Med Res Opin. 2015 Jun;31(6):1085-6. doi: 10.1185/03007995.2015.1035241. Epub 2015 May 15. Curr Med Res Opin. 2015. PMID: 25975357 No abstract available.